Literature DB >> 9543008

Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein.

C Brenner1, H C Pace, P N Garrison, A K Robinson, A Rosler, X H Liu, G M Blackburn, C M Croce, K Huebner, L D Barnes.   

Abstract

Fragile histidine triad protein (Fhit) is a diadenosine triphosphate (ApppA) hydrolase encoded at the human chromosome 3 fragile site which is frequently disrupted in tumors. Reintroduction of FHIT coding sequences to cancer cell lines with FHIT deletions suppressed the ability of these cell lines to form tumors in nude mice even when the reintroduced FHIT gene had been mutated to allow ApppA binding but not hydrolysis. Because this suggested that the tumor suppressor activity of Fhit protein depends on substrate-dependent signaling rather than ApppA catabolism, we prepared two crystalline forms of Fhit protein that are expected to model its biologically active, substrate-bound state. Wild-type and the His96Asn forms of Fhit were overexpressed in Escherichia coli, purified to homogeneity and crystallized in the presence and absence of ApppA and an ApppA analog. Single crystals obtained by vapor diffusion against ammonium sulfate diffracted X-rays to beyond 2.75 A resolution. High quality native synchrotron X-ray data were collected for an orthorhombic and a hexagonal crystal form.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9543008      PMCID: PMC2556046          DOI: 10.1093/protein/10.12.1461

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  27 in total

1.  Structure-based analysis of catalysis and substrate definition in the HIT protein family.

Authors:  C D Lima; M G Klein; W A Hendrickson
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

2.  Two hydrolase resistant analogues of diadenosine 5',5"'-P1,P3-triphosphate for studies with Fhit, the human fragile histidine triad protein.

Authors:  G M Blackburn; X Liu; A Rösler; C Brenner
Journal:  Nucleosides Nucleotides       Date:  1998 Jan-Mar

3.  Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.

Authors:  V Shridhar; L Wang; R Rosati; W Paradee; R Shridhar; C Mullins; W Sakr; D Grignon; O J Miller; Q C Sun; J Petros; D I Smith
Journal:  Oncogene       Date:  1997-03-20       Impact factor: 9.867

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins.

Authors:  C Brenner; P Garrison; J Gilmour; D Peisach; D Ringe; G A Petsko; J M Lowenstein
Journal:  Nat Struct Biol       Date:  1997-03

6.  Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.

Authors:  D B Zimonjic; T Druck; M Ohta; K Kastury; C M Croce; N C Popescu; K Huebner
Journal:  Cancer Res       Date:  1997-03-15       Impact factor: 12.701

7.  Replacement of Fhit in cancer cells suppresses tumorigenicity.

Authors:  Z Siprashvili; G Sozzi; L D Barnes; P McCue; A K Robinson; V Eryomin; L Sard; E Tagliabue; A Greco; L Fusetti; G Schwartz; M A Pierotti; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

8.  MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family.

Authors:  C D Lima; K L D'Amico; I Naday; G Rosenbaum; E M Westbrook; W A Hendrickson
Journal:  Structure       Date:  1997-06-15       Impact factor: 5.006

9.  The HIT protein family: a new family of proteins present in prokaryotes, yeast and mammals.

Authors:  B Séraphin
Journal:  DNA Seq       Date:  1992

10.  Three-dimensional structure of galactose-1-phosphate uridylyltransferase from Escherichia coli at 1.8 A resolution.

Authors:  J E Wedekind; P A Frey; I Rayment
Journal:  Biochemistry       Date:  1995-09-05       Impact factor: 3.162

View more
  13 in total

1.  Two hydrolase resistant analogues of diadenosine 5',5"'-P1,P3-triphosphate for studies with Fhit, the human fragile histidine triad protein.

Authors:  G M Blackburn; X Liu; A Rösler; C Brenner
Journal:  Nucleosides Nucleotides       Date:  1998 Jan-Mar

2.  Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.

Authors:  H C Pace; P N Garrison; A K Robinson; L D Barnes; A Draganescu; A Rösler; G M Blackburn; Z Siprashvili; C M Croce; K Huebner; C Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 3.  The histidine triad superfamily of nucleotide-binding proteins.

Authors:  C Brenner; P Bieganowski; H C Pace; K Huebner
Journal:  J Cell Physiol       Date:  1999-11       Impact factor: 6.384

4.  Fhit-nucleotide specificity probed with novel fluorescent and fluorogenic substrates.

Authors:  A Draganescu; S C Hodawadekar; K R Gee; C Brenner
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

5.  A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1.

Authors:  Jennifer A Boylston; Charles Brenner
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Fhit is a physiological target of the protein kinase Src.

Authors:  Yuri Pekarsky; Preston N Garrison; Alexey Palamarchuk; Nicola Zanesi; Rami I Aqeilan; Kay Huebner; Larry D Barnes; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

Review 7.  Fragile histidine triad protein: structure, function, and its association with tumorogenesis.

Authors:  Md Imtaiyaz Hassan; Abdullah Naiyer; Faizan Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-24       Impact factor: 4.553

8.  Tanshinones induce tumor cell apoptosis via directly targeting FHIT.

Authors:  Xianglian Zhou; Yuting Pan; Yue Wang; Bojun Wang; Yu Yan; Yi Qu; Xisong Ke
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

9.  Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.

Authors:  S Semba; F Trapasso; M Fabbri; K A McCorkell; S Volinia; T Druck; D Iliopoulos; Y Pekarsky; H Ishii; P N Garrison; L D Barnes; C M Croce; K Huebner
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 8.756

10.  Di-, tri- and tetra-5'-O-phosphorothioadenosyl substituted polyols as inhibitors of Fhit: Importance of the alpha-beta bridging oxygen and beta phosphorus replacement.

Authors:  James M Varnum; Janina Baraniak; Renata Kaczmarek; Wojciech J Stec; Charles Brenner
Journal:  BMC Chem Biol       Date:  2001
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.